taurine has been researched along with Heart Valve Diseases in 6 studies
Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a double-blind, randomized, crossover, placebo-controlled study, we investigated the effects of adding taurine to the conventional treatment in 14 patients with congestive heart failure for a 4-week period." | 9.05 | Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. ( Awata, N; Azuma, J; Hamaguchi, T; Harada, H; Hasegawa, H; Ishiyama, T; Ohta, H; Sawamura, A; Takihara, K; Yamagami, T, 1985) |
| "In a double-blind, randomized, crossover, placebo-controlled study, we investigated the effects of adding taurine to the conventional treatment in 14 patients with congestive heart failure for a 4-week period." | 5.05 | Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. ( Awata, N; Azuma, J; Hamaguchi, T; Harada, H; Hasegawa, H; Ishiyama, T; Ohta, H; Sawamura, A; Takihara, K; Yamagami, T, 1985) |
| "Taurine is a free β-amino acid and plays important physiological roles including protective effect of cardiovascular events." | 1.38 | Taurine suppresses osteoblastic differentiation of aortic valve interstitial cells induced by beta-glycerophosphate disodium, dexamethasone and ascorbic acid via the ERK pathway. ( Feng, X; Gu, L; Hu, YR; Li, JM; Liao, XB; Shang, BP; Sheng, ZF; Tang, H; Xie, H; Yuan, LQ; Zhang, W; Zhang, ZY; Zhou, XM, 2012) |
| "The taurine content was estimated from blood platelets and from the right atrial appendage removed during open heart surgery in 43 patients suffering from ischaemic heart disease." | 1.26 | Taurine in human auricular myocardium and blood platelets. ( Himberg, JJ; Merikallio, E; Paasonen, MK; Penttilä, O; Siltanen, P; Solatunturi, E, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Wesselowski, S | 1 |
| Blake, AB | 1 |
| Gordon, SG | 1 |
| Suchodolski, JS | 1 |
| Steiner, JM | 1 |
| Laflamme, DP | 1 |
| Averin, E | 1 |
| Feng, X | 1 |
| Li, JM | 1 |
| Liao, XB | 1 |
| Hu, YR | 1 |
| Shang, BP | 1 |
| Zhang, ZY | 1 |
| Yuan, LQ | 1 |
| Xie, H | 1 |
| Sheng, ZF | 1 |
| Tang, H | 1 |
| Zhang, W | 1 |
| Gu, L | 1 |
| Zhou, XM | 1 |
| Paasonen, MK | 1 |
| Penttilä, O | 1 |
| Merikallio, E | 1 |
| Siltanen, P | 1 |
| Himberg, JJ | 1 |
| Solatunturi, E | 1 |
| Azuma, J | 1 |
| Sawamura, A | 1 |
| Awata, N | 1 |
| Ohta, H | 1 |
| Hamaguchi, T | 1 |
| Harada, H | 1 |
| Takihara, K | 1 |
| Hasegawa, H | 1 |
| Yamagami, T | 1 |
| Ishiyama, T | 1 |
1 review available for taurine and Heart Valve Diseases
| Article | Year |
|---|---|
Key nutrients important in the management of canine myxomatous mitral valve disease and heart failure.
Topics: Animals; Dog Diseases; Dogs; Fatty Acids, Omega-3; Heart Failure; Heart Valve Diseases; Humans; Lysi | 2022 |
2 trials available for taurine and Heart Valve Diseases
| Article | Year |
|---|---|
Use of taurine during rehabilitation after cardiac surgery.
Topics: Adult; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Chronic Disease; Female; Heart Failure; | 2015 |
Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial.
Topics: Administration, Oral; Aged; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Drug Th | 1985 |
3 other studies available for taurine and Heart Valve Diseases
| Article | Year |
|---|---|
Whole blood and plasma taurine reference intervals in adult Cavalier King Charles Spaniels and correlations between taurine concentration, diet and mitral valve disease.
Topics: Animals; Diet; Dog Diseases; Dogs; Heart Valve Diseases; Mitral Valve; Taurine | 2022 |
Taurine suppresses osteoblastic differentiation of aortic valve interstitial cells induced by beta-glycerophosphate disodium, dexamethasone and ascorbic acid via the ERK pathway.
Topics: Adult; Alkaline Phosphatase; Aortic Valve; Ascorbic Acid; Bicuspid Aortic Valve Disease; Biomarkers; | 2012 |
Taurine in human auricular myocardium and blood platelets.
Topics: Adult; Blood Platelets; Coronary Disease; Female; Heart Atria; Heart Diseases; Heart Failure; Heart | 1982 |